About Himalaya Nutravedics India Ltd IPO
Himalaya Nutravedics India IPO is a book-built issue comprising a fresh issue of up to ?26.50 crore. The Equity Shares are proposed to be listed on the BSE SME, with Nirbhay Capital Services Private Limited acting as the Book Running Lead Manager and KFin Technologies Limited as the Registrar to the Issue.
The Company is promoted by Rohit Asawa, Divya Asawa, Chanda Asawa and Rama Raju Penmatsa.
The proceeds from the fresh issue are proposed to be utilised towards funding working capital requirements, business development and digital marketing activities, and general corporate purposes.
About Himalaya Nutravedics India Limited
Himalaya Nutravedics India Limited is an Ayurvedic and Nutraceutical company engaged in the manufacturing, marketing and distribution of its own products, along with third-party contract manufacturing for other companies.
Incorporated in June 2022, Himalaya Nutravedics India Limited operates across both branded Ayurvedic and nutraceutical products and third-party manufacturing, providing a hybrid business model. Its product portfolio includes Classical Ayurvedic formulations, Proprietary Ayurvedic formulations and Nutraceutical supplements. The Company manufactures products in various dosage forms, including softgels, hardgel capsules, tablets, liquid orals, medicated oils and protein powders.
As of March 31, 2026, the own-brand business contributed ?2,202.54 lakh, representing approximately 51.14% of total revenue, indicating that own products have become a significant contributor to the Company’s overall business.
The Company’s manufacturing operations are supported by an integrated facility in Cherlapally, Hyderabad, enabling it to manage the key stages of production from formulation and manufacturing through quality control, packaging and product release under one roof. The facility is designed to manufacture multiple dosage forms and operates in compliance with WHO-GMP standards, with applicable AYUSH and FSSAI registrations and licences.
The facility also holds certifications including ISO 9001:2015, ISO 22000:2018, HACCP, HALAL and KOSHER, supporting the Company’s quality and manufacturing standards.
Its products are marketed across multiple states in India through a stockist and super-stockist driven distribution network, supported by a doctor-centric, prescription-led sales model. The Company has a growing presence across markets including Telangana, Andhra Pradesh, Kerala, Gujarat and Uttar Pradesh.
As of July 31, 2026, the Company’s operations were supported by 86 full-time employees across its key business and support functions, including marketing, manufacturing, finance, quality, compliance and administration.
Himalaya Nutravedics India IPO is a book-built issue comprising a fresh issue of up to ?26.50 crore. The Equity Shares are proposed to be listed on the BSE SME, with Nirbhay Capital Services Private Limited acting as the Book Running Lead Manager and KFin Technologies Limited as the Registrar to the Issue. The Company is promoted by Rohit Asawa, Divya Asawa, Chanda Asawa and Ra
Himalaya Nutravedics IPO Subscription Breakdown
| Investory Category | Subscription Percentage | Amount Raised (₹ Crores) |
|---|---|---|
| Qualified Institutional Buyers (QIBs) | 49.9% | 8,92,810.8 crores |
| Non-Institutional Investors (NIIs) | 15.02% | 2,68,737.84 crores |
| Retail Individual Investors (RIIs) | 35.08% | 6,27,651.36 crores |
Himalaya Nutravedics IPO Strengths & Weaknesses
An integrated manufacturing facility enables the Company to produce softgels, hardgel capsules, tablets, liquid orals and medicated oils, catering to diverse Ayurvedic and nutraceutical product requirements.
The Company follows a doctor-focused, prescription-led marketing approach supported by scientific detailing, CME programmes, medical camps and practitioner engagement.
The Company has established ongoing relationships with healthcare practitioners, stockists and third-party manufacturing customers, supporting repeat orders and customer continuity.
The Company has expanded its presence across multiple states in India, with stronger revenue contribution from Telangana, Andhra Pradesh, Kerala, Gujarat and Uttar Pradesh.
The Company has a diversified portfolio where it offers Classical Ayurvedic, Proprietary Ayurvedic and Nutraceutical products across therapeutic and wellness categories including gut health, metabolic wellness, pain management, immunity and general wellness.
Himalaya Nutravedics IPO Important Dates & Issue Details
| Allotment Date | Listing Date | Refund Date |
|---|---|---|
| 25 Sep '26 | 29 Sep '26 | 28 Sep '26 |
| Issue Composition: | |
|---|---|
| Face Value | ₹10 per share |
| Total Issue Size | 17,89,200 shares (aggregating up to ₹2,54,400 crores) |
| Fresh Issue | 2,37,360 shares (aggregating up to ₹23,73,600 crores) |
| Offer for Sale | 0 shares of ₹10 (aggregating up to To be announced) |
| Issue Type | Book Building IPO |
| Post-Issue Shareholding Pattern: | |
|---|---|
| Pre-Issue Shareholding | 100 shares |
| Post-Issue Shareholding | 100 shares |
Himalaya Nutravedics IPO Lot Size and Investment Details
| Minimum Lot Size | -- |
| Maximum Lot Size (Retail) | -- |
The lot size of Himalaya Nutravedics ipo has been designed to ensure broad participation while maintaining optimal price discovery.
How to Apply for Himalaya Nutravedics IPO
- Log in to your Choice account
- Select IPO
- Enter the number of lots and your price
- Verify UPI ID
- Complete the transaction on your UPI app
Himalaya Nutravedics IPO Contact & Registrar Details
Contact Details
Address
Plot No 101 / A Phase- I I I Industrial Development Park Cherlapally, Hindustan Cables Ltd, Uppal Hyderabad
Phone Number
Registrar Details
Registrar Name
Kfin Technologies Ltd.
Phone Number
Himalaya Nutravedics Lead Manager(s)
| Book Running Lead Manager(s) |
|---|
| Nirbhay Capital Services Pvt Ltd |
